CD4 and cryptococcosis: From these data, one may hypothesize that in patients with CD4 count ≤50 cells/μl and a higher cryptococcosis incidence, the prophylaxis strategy in addition to being a more effective strategy for cryptococcal infection prevention is probably associated with an acceptable cost-effective ratio.